Great West Life Assurance CO Aerie Pharmaceuticals Inc Transaction History

Great West Life Assurance CO

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 01, 2022	BUY	$6.37 - $15.23 $11,574 - $27,672	1,817 New	1,817 $27,000
Q2 2021 Aug 11, 2021	SELL	$15.16 - $18.97 $21,087 - $26,387	-1,391 Reduced 43.36%	1,817 $29,000
Q3 2020 Nov 17, 2020	BUY	$10.46 - $14.46 $32,582 - $45,042	3,115 Added 3349.46%	3,208 $37,000
Q3 2020 Nov 13, 2020	SELL	$10.46 - $14.46 $32,582 - $45,042	-3,115 Reduced 97.1%	93 $1,000
Q4 2019 Feb 11, 2020	BUY	$17.72 - $25.1 $56,845 - $80,520	3,208 New	3,208 $77,000
Q3 2019 Oct 25, 2019	SELL	$18.41 - $28.0 $111,306 - $169,288	-6,046 Closed	0 $0
Q2 2019 Jul 31, 2019	BUY	$28.97 - $48.21 $13,644 - $22,706	471 Added 8.45%	6,046 $0
Q1 2019 May 08, 2019	BUY	$36.32 - $49.25 $51,392 - $69,688	1,415 Added 34.01%	5,575 $264,000
Q3 2017 Nov 09, 2017	BUY	$48.6 - $60.1 $202,176 - $250,016	4,160	4,160 $204,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

Stay updated on Great West Life Assurance CO with notifications on news.